Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 126-127, 2001;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salem, R. O.
Right arrow Articles by Laposata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salem, R. O.
Right arrow Articles by Laposata, M.
Related Collections
Right arrow Laboratory Management
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2001;47:126-127.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Effect of Specimen Anticoagulant and Storage on Measurement of Serum and Plasma Fatty Acid Ethyl Ester Concentrations.

Raneem O. Salem1, Joanne E. Cluette-Brown1, Ali Hasaba1 and Michael Laposata1,a

1 Division of Laboratory Medicine, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
a Address correspondence to this author at: Room 235, Gray Bldg., Massachusetts General Hospital, Boston, MA 02114; fax 617-726-3256, mlaposata{at}partners.org

Fatty acid ethyl esters (FAEEs) are cytotoxic nonoxidative metabolites of ethanol that are produced by esterification of alcohol and fatty acids (1)(2)(3). After ethanol intake, FAEEs are found mainly in the liver, pancreas, heart, and brain, which are the major organs adversely affected by ethanol intake (4)(5). FAEEs are detectable in the blood for up to 24 h after consumption of ethanol to at least 600 mg/L (6)(7)(8), making the presence of FAEEs in blood a useful marker for ethanol intake. This investigation presents the results of studies on the effects of collection tube, storage time, and storage temperature on FAEE concentrations in blood, with the goal of creating a reliable clinical assay for serum and plasma FAEE quantification.

Four volunteers participated in this study. Each subject was given a weight-adjusted amount of 100-proof vodka mixed with fruit juice in a 1:3 ratio (8). The vodka-juice beverage was divided into nine equal aliquots, which were administered every 10 min over a 90-min time period. After the last aliquot was drunk, blood samples were collected in four different 5-mL Vacutainer Tubes from each subject to assess the influence of the collection tube on the blood FAEE concentration. The tubes included a red-top tube with no anticoagulant, a purple-top tube with 150 g/L EDTA, a green-top tube with 72 USP units of heparin, and a blue-top tube with 32 g/L sodium citrate. The tubes were kept on ice and processed within 30 min. FAEEs were then isolated and quantified as described below. To study the effect of storage time and temperature on FAEE concentrations in whole blood, 40 mL of blood was collected from each of the same four subjects in red-top vacuum tubes (no anticoagulant). The 40 mL of blood was divided into two equal aliquots that were incubated at 25 and 37 °C for 0, 2, 4, 6, 24, and 48 h. FAEEs were then isolated from the samples. To accomplish this, serum or plasma was first separated from the blood cells by centrifugation at 3420g at 4 °C for 20 min. FAEEs were then isolated using an acetone-hexane (2:8 by volume) extraction followed by solid-phase extraction (9), and measured using gas chromatography–mass spectrometry as described previously (10). The within-assay CV for the entire method was 17%. The CVs for the individual stages were as follows: FAEE isolation via liquid extraction, ~13%; solid-phase extraction, ~9.7%; and quantification by gas chromatography–mass spectrometry, ~2.2%.

The effect of the collection tube on the amounts of FAEE in plasma or serum is shown in Table 1 . For the four volunteers, the mean concentrations of FAEE in the sodium citrate tube, the heparin tube, and the anticoagulant-free tube were similar. However, the EDTA vacuum tube showed a lower FAEE concentration than the others. We speculate that the extensive chelation of calcium by EDTA contributed to this observation in some way. The mean FAEE concentrations in plasma in the sodium citrate and heparin tubes, and in serum in the anticoagulant-free tubes, were more than twice the mean plasma FAEE concentration in the EDTA tubes. The variability was least for sodium citrate tubes. This higher precision suggests the use of 32 g/L sodium citrate as the preferred anticoagulant.


View this table:
[in this window]
[in a new window]
 
Table 1. Relative amounts of FAEE detected in different blood collection tubes.

Storage time and temperature also affected FAEE concentrations in serum. The FAEE concentration increased over time when incubated as whole blood at 25 and 37 °C. As shown in Fig. 1 , there was a rapid increase in FAEE concentrations at 37 °C from 2273 ± 507 nmol/L (mean ± SE) at time 0 to 4826 ± 245 nmol/L (mean ± SE) 48 h after blood collection. At 25 °C, there was no change in the FAEE concentration after up to 4 h of incubation: 1712 ± 385 nmol/L at time 0 and 1766 ± 486 nmol/L at 4 h (mean ± SE for both). However, there was an increase to 4750 ± 875 nmol/L (mean ± SE) with storage at 25 °C for 48 h. There was less variability, in general, for the samples stored at 37 °C, but this higher precision is not likely to have a biological basis.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 1. Effect of time on serum FAEE concentrations at 25 and 37 °C.

Blood samples were collected from four healthy subjects and then incubated for different times before collection of serum. The sera were separated and processed for FAEE measurements as described in the text. Each point represents the mean ± SE (bars); n = 4/time point. The differences in mean values are not statistically significant for each time point at 25 vs 37 °C. However, the values at 25 °C at time 0 are different from those at 48 h (P = 0.01), and they approach statistical significance from those at 24 h (P = 0.07). The values at 37 °C at time 0 are different from those at 24 and 48 h (P = 0.05 and P = 0.04, respectively).

The in vitro formation of FAEEs, which is fastest at 37 °C, is most likely the result of enzyme-mediated FAEE synthesis using the residual ethanol in the specimen collection tubes. Ethanol remains in the blood for up to 6 h. White bloods cells, platelets, and to a lesser extent, red blood cells, have been shown to have FAEE synthase activity (11). A previously published study from our laboratory with plasma and serum samples from individuals in a clinical trial involving ethanol ingestion showed no changes in FAEE concentration after 2 days of storage at -4 or -80 °C (12). Taken together, the results of the current storage experiments and our previously reported findings indicate a need for removal of the plasma or serum from the cells within 4 h at room temperature, with freezing of plasma or serum at -4 °C or -80 °C if longer periods of time are required before analysis of the specimen. In addition, samples should not be collected for FAEE analysis in EDTA-containing vacuum tubes.


References

  1. Laposata M. Fatty acid ethyl esters: short term and long term serum markers of ethanol intake. Clin Chem 1997;43:1527-1534.[Abstract/Free Full Text]
  2. Newsome WH, Rattray JBM. The enzymatic esterification of ethanol with fatty acids. Can J Biochem 1965;43:1223-1233.
  3. Goodman DS, Deykin D. Fatty acid ethyl ester formation during ethanol metabolism in vivo. Proc Soc Exp Biol Med 1963;113:65-70.
  4. Laposata M, Szczepiorkowski ZM, Cluette-Brown JE. Fatty acid ethyl esters: non-oxidative metabolites of ethanol. Prostaglandins Leukot Essent Fatty Acids 1995;52:87-91.[ISI][Medline] [Order article via Infotrieve]
  5. Laposata EA, Lange LG. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 1986;231:497-499.[Abstract/Free Full Text]
  6. Lundquist F. The metabolism of ethanol. In: Israel Y, Mardonec J, eds. Biological basis of alcoholism. New York: John Wiley & Sons, 1971:110–5..
  7. Doyle KM, Bird DA, Al-Salihi S, Hallaq Y, Cluette-Brown JE, Goss KA, Laposata M. Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res 1994;35:428-437.[Abstract]
  8. Doyle KM, Cluette-Brown JE, Dube DM, Bernhardt TG, Morse CR, Laposata M. Fatty ethyl esters in the blood as a markers for ethanol intake. JAMA 1996;276:1152-1156.[Abstract]
  9. Bernhardt TG, Cannistraro PA, Bird DA, Doyle KM, Laposata M. Purification of fatty acid ethyl esters by solid phase extraction and HPLC. J Chromatogr B 1996;675:189-196.[Medline] [Order article via Infotrieve]
  10. Dan L, Cluette-Brown JE, Kabakibi A, Laposata M. Quantitation of the mass of fatty acid ethyl esters synthesized by Hep G2 cells incubated with ethanol. Alcohol Clin Exp Res 1998;22:1125-1131.[ISI][Medline] [Order article via Infotrieve]
  11. Gorski NP, Nouraldin H, Dube DM, Preffer FI, Dombkowski DM, Villa EM, et al. Reduced fatty acid ester synthase activity in white blood cells of alcoholics. Alcohol Clin Exp Res 1996;20:268-274.[ISI][Medline] [Order article via Infotrieve]
  12. Soderberg BL, Sicinska ET, Boldget E, Cluette-Brown JE, Suter PM, Schuppisser T, et al. Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples. Clin Chem 1999;45:2183-2190.[Abstract/Free Full Text]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salem, R. O.
Right arrow Articles by Laposata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salem, R. O.
Right arrow Articles by Laposata, M.
Related Collections
Right arrow Laboratory Management
Right arrow Drug Monitoring and Toxicology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS